Celebrating its 10-year anniversary, the Alzheimer’s Therapeutic Research Institute (ATRI), a San Diego–based center established by Keck School of Medicine of USC researchers, is predicting how Alzheimer’s disease treatment will advance in the decade to come. Leaders from USC ATRI say that as screening and preventive care become routine, new treatments will be able to stop symptoms years before cognitive decline can begin.

“This is a pivotal moment. We’re now on a course towards prevention, with better trials for even better treatments. Everything has changed,” said Paul Aisen, MD, founding director of ATRI, and a leading global figure in Alzheimer’s disease research.

To read more, click here.